Navigation Links
Vaccine For Dengue Fever On Trial In Asia-Pacific

A dengue fever vaccine full of promise is being tried in the Asia Pacific region, says drug giant GlaxoSmithKline. Earlier trials of the GlaxoSmithKline vaccine //have been completed in the US and further testing on a few hundred Thai volunteers should be finished by the end of next year, Dr. Hans L. Bock told the Straits Times.

"We have a strong interest in making the vaccine available fast, given that this is an issue of major public need," said Bock, vice president and director of clinical research for GSK biologicals in the Asia-Pacific, Australasia, China, Hong Kong and Japan.

At the end of last month, more than 12,700 people in Singapore had been afflicted by the viral disease spread by the Aedes mosquito, surpassing last year's record high of 9,459. Fourteen had died.

The largest and most important stage three trial, expected to involve 10,000 toddlers and young children in Thailand and Malaysia, is forecast to take a further three years, Bock told the newspaper.

Dengue leaves an average of 400,000 people in hospitals throughout Southeast Asia every year and causes about 3,000 deaths.

There is currently no vaccine or medication against dengue, which is endemic in the region.

Bock said Singapore could play a critical role in reviewing the vaccine and serving as "a reference country".

A stamp of approval here would give other countries the confidence to shorten or do away with their own approval processes, he said, getting the vaccine approved by 2010, one or two years ahead of schedule.

The drug company contends its vaccine is the frontrunner in the race to develop one against dengue.
'"/>




Page: 1

Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. A new Vaccine for Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/31/2016)... , ... May 31, 2016 , ... WaterField Designs, an ... professionals, announces the waxed-canvas and leather Duo Dopp Kit , the ideal gift ... or ballistic nylon, the Duo is smartly designed for Dad’s grooming routine. ...
(Date:5/31/2016)... CA (PRWEB) , ... May 31, 2016 , ... Interest ... a primary screening tool and as an orthogonal tool for RNAi hit validation. A ... functional and specific guide RNAs—allows rapid generation of CRISPR RNA (crRNA) collections in arrayed ...
(Date:5/31/2016)... ... 2016 , ... MinerEye today announced that it has been ... by Gartner1 Inc. , Each year, Gartner identifies new Cool Vendors in key ... and their products and services. , According to Gartner, “Gartner's Cool Vendors in ...
(Date:5/31/2016)... ... May 31, 2016 , ... CURE Media Group ... cancer, has added Cancer and Careers to its Advocacy Spotlight ... on continuing successful careers while fighting cancer. , As partners, both organizations will ...
(Date:5/30/2016)... , ... May 30, 2016 , ... ... businesses, announced today the publication of an original infographic, " Health Benefits Reimbursement ... insurance professionals understand how Zane Benefits complies with various federal regulations and reforms. ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... 26, 2016   Change Healthcare , ... network solutions and technology-enabled services designed to ... into a strategic channel partnership with SourceMed, ... solutions and revenue cycle management services that ... rehabilitation clinics to optimize revenue, operational efficiency ...
(Date:5/25/2016)... FDA 510(k) clearance covers Confocal Miniprobes ... and surgical applications Mauna Kea Technologies ... multidisciplinary confocal laser endomicroscopy (CLE) platform, today announced ... the 12 th 510(k) clearance from United ... FDA clearance covers Confocal Miniprobes indicated for use ...
(Date:5/25/2016)... , Deutschland und GERMANTOWN, Maryland ... Zusammenarbeit mit Therawis bedient dringenden ... Brustkrebs   QIAGEN N.V. (NASDAQ: ... heute bekannt, eine Lizenz- und Entwicklungsvereinbarung mit Therawis ... für die Onkologie eingegangen zu sein. Ein erstes ...
Breaking Medicine Technology: